Pfizer Sees Significant Profit Boost from COVID-19 Products and Reduced Expenses
Pfizer's profits have increased due to the success of its COVID-19 products and lower operational…
pharmaceuticals
Pfizer’s Q2 Results Reveal Significant Sales Growth, Boosts Profit Forecast for 2025
Pfizer's Q2 sales jump to $14.65 billion, driven by strong demand for its pharmaceutical products,…
Revolutionizing Healthcare: Rpharmy Unveils Groundbreaking Hazardous Drug Risk Initiative
Rpharmy to showcase innovative hazardous drug risk initiative at Florida Society of Health System Pharmacists…
Biomark Diagnostics Inc. Expands Specialty Laboratory Services in Quebec to Meet Growing Demand
Biomark Diagnostics Inc. announces the expansion of its specialty laboratory services in Quebec to accommodate…
Pfizer Boosts Annual Profit Forecast Amidst Strong Pharmaceutical Sales
Pfizer increases annual profit forecast due to robust sales of its pharmaceutical products, driven by…
Pfizer Stock Soars: A $1,000 Investment Now Worth Over $114,500
A $1,000 investment in Pfizer stock 20 years ago would be worth over $114,500 today,…
Revolutionary Pill-Based Alternative to Injections Developed by Bath Researchers
A team of researchers from the University of Bath has successfully developed a pill-based alternative…
Egypt Sees 43% Surge in Foreign Pharmaceutical Sales in 2024
Foreign pharmaceutical sales in Egypt have witnessed a significant leap of 43% year-over-year in 2024,…
Federal Agency Faces Deep Staff Cuts, Sparking Concerns Over Public Health and Safety
A little-known federal agency is facing significant staff reductions, raising concerns about the impact on…